China Pharma Holdings (CPHI) Inventory Average (2011 - 2026)

China Pharma Holdings has reported Inventory Average for 16 years, with the latest figure at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 23.94% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (down 23.94% YoY), and the FY2025 full-year result was $2.8 million, down 14.69% from the prior year.
• Inventory Average for Q1 2026 stood at $2.1 million, down from $2.8 million in the prior quarter.
• The five-year high for Inventory Average was $3.8 million in Q3 2023, with the low at $2.1 million in Q1 2026.
• Historically, Inventory Average has averaged $3.1 million across 5 years, with a median of $3.2 million in 2022.
• Annual changes were most pronounced in 2023 — Inventory Average gained 28.53% — and 2024, when it plunged 30.76%.
• China Pharma Holdings' Inventory Average stood at $2.9 million in 2022, then gained by 28.53% to $3.7 million in 2023, then declined by 28.81% to $2.7 million in 2024, then rose by 3.17% to $2.8 million in 2025, then slipped by 22.57% to $2.1 million in 2026.
• The last three Inventory Average figures came in at $2.1 million (Q1 2026), $2.8 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.